Predictive Models of Toxicity With External Radiotherapy for Prostate Cancer Clinical Issues

被引:28
作者
Valdagni, Riccardo [1 ]
Rancati, Tiziana [1 ]
Fiorino, Claudio [2 ]
机构
[1] Natl Canc Inst, Sci Directorate, Prostate Program, I-20133 Milan, Italy
[2] Hosp San Raffaele, Dept Med Phys, I-20132 Milan, Italy
关键词
prostate cancer; radio-induced toxicity prediction; conformal radiotherapy; nomograms; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; DOSE-VOLUME ANALYSIS; PRETREATMENT NOMOGRAM; RADIATION-THERAPY; ANDROGEN DEPRIVATION; RECTAL TOXICITY; SMALL-BOWEL; GASTROINTESTINAL TOXICITY; RADICAL PROSTATECTOMY; URINARY TOXICITY;
D O I
10.1002/cncr.24356
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The objective of the current study was to analyze the state of the art and present limitations of available predictive clinical models (when available) estimating the risk of genitourinary tract and small bowel complications, erectile dysfunction, and acute and late symptoms of the rectal syndrome caused by prostate cancer external irradiation. An analysis of the literature indicated that very limited attention has been devoted to the development of "integrated," patient-tailored, user-friendly, and clinically usable tools for the prediction of external beam radiotoxicity. In this article, the authors reported on the multivariate correlation between late genitourinary and gastrointestinal toxicities and clinical/dosimetric risk factors, as well as on the first set of nomograms developed to predict acute and late rectal side effects. At the present state of knowledge, the use of nomograms as predictive instruments of radiotoxicity appears to be particularly attractive for several main reasons. They are "user friendly" and easily developed using the results of multivariate analyses, as they weigh the combined effects of multiple independent factors found to be correlated with the selected clinical endpoint. The integrated evaluation of clinical and dosimetric parameters in the single patient can help to provide a tailored probability of the specific outcome considered. Predicting a high probability of toxicity could avoid unnecessary daily costs for the individual patient in terms of quality of life modification during and after treatment, helping patients in the decision-making process of choosing the best individual, quality of life-related treatment, and clinicians in better tailoring the treatment to patient's characteristics. Cancer 2009;115(13 suppl):3141-3149. (C) 2009 American Cancer Society
引用
收藏
页码:3141 / 3149
页数:9
相关论文
共 42 条
[1]   Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes [J].
Cahlon, Oren ;
Zelefsky, Michael J. ;
Shippy, Alison ;
Chan, Heather ;
Fuks, Zvi ;
Yamada, Yoshiya ;
Hunt, Margie ;
Greenstein, Steven ;
Amols, Howard .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (02) :330-337
[2]   Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer [J].
Chan, Linda W. ;
Xia, Ping ;
Gottschalk, Alexander R. ;
Akazawa, Michelle ;
Scala, Matthew ;
Pickett, Bary ;
Hsu, I-Chow ;
Speight, Joycelyn ;
Roach, Mack, III .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01) :69-77
[3]   Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer [J].
Cheung, M. Rex ;
Tucker, Susan L. ;
Dong, Lei ;
de Crevoisier, Renaud ;
Lee, Andrew K. ;
Frank, Steven ;
Kudchadker, Rajat J. ;
Thames, Howard ;
Mohan, Radhe ;
Kuban, Deborah .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (04) :1059-1065
[4]   Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 GY) [J].
Cozzarini, C ;
Fiorino, C ;
Ceresoli, GL ;
Cattaneo, GM ;
Bolognesi, A ;
Calandrino, R ;
Villa, E .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (03) :688-694
[5]   Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Fondurulia, J ;
Chen, MH ;
Kaplan, I ;
Beard, CJ ;
Tomaszewski, JE ;
Renshaw, AA ;
Wein, A ;
Coleman, CN .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :168-172
[6]   Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy [J].
Feigenberg, SJ ;
Hanlon, AL ;
Horwitz, EM ;
Uzzo, RG ;
Eisenberg, D ;
Pollack, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (02) :397-405
[7]   Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer [J].
Fiorino, C ;
Sanguineti, G ;
Cozzarini, C ;
Fellin, G ;
Foppiano, F ;
Menegotti, L ;
Piazzolla, A ;
Vavassori, V ;
Valdagni, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (04) :953-962
[8]  
FIORINO C, INT J RAD O IN PRESS
[9]   Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: Preliminary results of a multicenter prospective study [J].
Fiorino, Claudio ;
Fellm, Gianni ;
Rancati, Tiziana ;
Vavassori, Vitrorio ;
Bianchi, Carla ;
Borca, Valeria Casanova ;
Girelli, Giuseppe ;
Mapelli, Marco ;
Menegotti, Loris ;
Nava, Simona ;
Valdagni, Riccardo .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04) :1130-1137
[10]   Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate [J].
Gulliford, SL ;
Webb, S ;
Rowbottom, CG ;
Corne, DW ;
Dearnaley, DP .
RADIOTHERAPY AND ONCOLOGY, 2004, 71 (01) :3-12